A diagnostic methodology that assesses the responsiveness of various target tissues, such as muscle, fat, liver, or reproductive organs, to circulating hormones like insulin, estrogen, or androgens, independent of systemic hormone levels. This mapping identifies localized areas of resistance or hypersensitivity within the body’s endocrine landscape. Understanding this provides a finer resolution for therapeutic intervention than serum testing alone.
Origin
The term draws from endocrinology and molecular biology, where receptor function is mapped across different anatomical sites. “Tissue Sensitivity” refers to the magnitude of cellular response to a given hormone concentration, and “Mapping” denotes the systematic documentation of these responses across multiple sites. It reflects a shift toward tissue-specific endocrinology.
Mechanism
The operational mechanism often involves measuring downstream cellular events in response to controlled hormonal challenge or analyzing receptor density and post-receptor signaling integrity at the cellular level. For example, assessing glucose uptake in muscle versus adipose tissue reveals differential insulin sensitivity, which is a key component of this map. This analysis elucidates why systemic hormone levels might appear normal while specific physiological outcomes remain suboptimal due to localized resistance or hypersensitivity.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.